Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans

NCT02117206 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Skeletal Muscle Ischemia
Severe Lower Limb Ischemia
Mitochondrial Dysfunction

Interventions

DRUG: L-arginine (L-arginine Veyron)
DRUG: Nacl

Sponsor

University Hospital, Strasbourg, France